A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers

NCT07650383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Adult Subjects

Interventions

DRUG: ENERGI-F705 Tablets 60 mg
DRUG: ENERGI-F705 Tablets 120 mg
DRUG: Vehicle Control

Sponsor

Energenesis Biomedical Co., Ltd.